Lv1
5 积分 2021-07-15 加入
Preclinical Characterization of 3β-(N-Acetyl l -cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
2天前
已完结
Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024)
2天前
已完结
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation
2天前
已完结
Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
3天前
已完结
Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
3天前
已完结
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
4天前
已完结
Synthesis of Micheliolide Derivatives and Their Activities against AML Progenitor Cells
4天前
已完结
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
22天前
已完结
Novel inhibitors of STAT3: an updated patent review (2022–present)
24天前
已完结
Fluorescent Coumarin–Artemisinin Conjugates as Mitochondria‐Targeting Theranostic Probes for Enhanced Anticancer Activities
27天前
已完结
皖公网安备34019202002308
